Your browser doesn't support javascript.
loading
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial.
Ständer, Sonja; Kwon, Paul; Hirman, Joe; Perlman, Andrew J; Weisshaar, Elke; Metz, Martin; Luger, Thomas A.
Afiliación
  • Ständer S; Center for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Münster, Germany. Electronic address: Sonja.Staender@uni-muenster.de.
  • Kwon P; Menlo Therapeutics Inc, Redwood City, California.
  • Hirman J; Pacific Northwest Statistical Consulting, Inc, Woodinville, Washington.
  • Perlman AJ; Velocity Pharmaceutical Development, LLC, South San Francisco, California.
  • Weisshaar E; Department of Clinical Social Medicine, Occupational and Environmental Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Metz M; Department of Dermatology, Venerology, and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Luger TA; Department of Dermatology, University Hospital Münster, Münster, Germany.
J Am Acad Dermatol ; 80(5): 1395-1402, 2019 May.
Article en En | MEDLINE | ID: mdl-30894279

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prurito / Isoindoles / Antagonistas del Receptor de Neuroquinina-1 Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prurito / Isoindoles / Antagonistas del Receptor de Neuroquinina-1 Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos